drugset / Trial / NCT00300118
Oral Budesonide vs. Oral Mesalazine in Active Crohn's Disease (CD)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine whether mesalazine or budesonide is more active in the treatment of active Crohn's disease.
Timeline
- Start
- 2004-09
- Primary completion
- 2008-05
- Completion
- 2008-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Budesonide | Small molecule | 9 mg | Oral |
| Comparator | Mesalamine | Small molecule | 4.5 g | Oral |